- Global Pharma News & Resources

Asklepios Kliniken: Asklepios attains 83% of the voting rights in RHÖN

DGAP-News: Asklepios Kliniken / Key word(s): Merger
18.06.2020 / 12:30
The issuer is solely responsible for the content of this announcement.

Asklepios attains 83% of the voting rights in RHÖN

  • Asklepios sees a 25.56% increase in the submitted voting rights in RHÖN and therefore has a share of 83%
  • Shareholders can tender their shares until 6 July

Hamburg, 18 June 2020. Asklepios Kliniken GmbH & Co. KGaA announces hereby that, as of 6:00 pm on 17 June 2020, around 22 million shares had been tendered as part of the voluntary public takeover offer to the shareholders of RHÖN-KLINIKUM AG. In total, this gives Asklepios a share in the voting rights of approximately 83%. Compared with the most recently published results, this equates to an increase of around 25% of the voting rights. This increase comes down largely to the acceptance of the takeover offer by B. Braun Melsungen AG. According to information from B. Braun Melsungen AG, the company accepted the takeover offer for the RHÖN shares that it holds. The additional acceptance period for the takeover offer ("wren rule") is scheduled to run from 23 June to 6 July 2020. All other RHÖN shareholders have time to accept the takeover offer until then.

"We are delighted about the high acceptance rate and see it as confirmation that our roadmap for the shared future with Asklepios is a good solution. With around 83% of the voting rights, we have the strong majority we need to initiate important strategic changes for RHÖN. This will benefit the hospitals in the Asklepios/RHÖN Group, their employees, and especially their patients. We assume that even more investors will tender their shares by 6 July, expected to be the last day of the additional acceptance period. After all, our offer price of EUR 18 is more than 22% higher than the last market price before the announcement of our decision to make a takeover offer on 28 February. In their respective substantiated statements, RHÖN's Management and Supervisory Boards also deemed the offer price to be appropriate and advised RHÖN shareholders to accept the offer," says Kai Hankeln, CEO of the Asklepios Group.

About Asklepios

Asklepios Kliniken is one of the leading private operators of hospitals and healthcare facilities in Germany. The hospital group stands for highly qualified care for its patients, with a clear commitment to medical quality, innovation and social responsibility. On this basis, Asklepios has grown dynamically since it was founded almost 35 years ago. The Group currently has around 160 healthcare facilities throughout Germany, including acute care hospitals for all levels of care, specialist clinics, psychiatric and forensic facilities, rehabilitation clinics, nursing homes and medical service centres. In the 2019 financial year, 2.5 million patients were treated at the Asklepios Group's facilities. The company has more than 49,000 employees.

IR contact
Mirjam Constantin
Investor Relations
Asklepios Kliniken GmbH & Co. KGaA
Debusweg 3
61462 Königstein-Falkenstein
Tel: +49 61 74 90-1166
Fax: +49 61 74 90-1110

PR contact:
Rune Hoffmann
Head of Corporate Communications & Marketing
Asklepios Kliniken GmbH & Co. KGaA
Rübenkamp 226
22307 Hamburg
Tel.: +49 40 1818-82 6630
Fax: +49 40 1818-82 6639

Visit Asklepios online, on Facebook or on YouTube:

18.06.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

Editor Details

Last Updated: 18-Jun-2020